Ellevest, Inc. Dynavax Technologies Corp Transaction History

Ellevest, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 04, 2023	SELL	$9.44 - $11.88 $651 - $819	-69 Reduced 69.7%	30 $0
Q4 2022 Feb 03, 2023	SELL	$10.27 - $13.29 $595 - $770	-58 Reduced 36.94%	99 $1,000
Q2 2022 Jul 18, 2022	SELL	$7.45 - $12.83 $819 - $1,411	-110 Reduced 41.2%	157 $2,000
Q1 2022 Apr 19, 2022	BUY	$9.75 - $14.44 $731 - $1,083	75 Added 39.06%	267 $3,000
Q2 2021 Jul 13, 2021	BUY	$7.25 - $10.99 $500 - $758	69 Added 56.1%	192 $2,000
Q1 2021 May 03, 2021	SELL	$4.57 - $11.18 $406 - $995	-89 Reduced 41.98%	123 $1,000
Q4 2020 Feb 04, 2021	SELL	$3.73 - $5.6 $324 - $487	-87 Reduced 29.1%	212 $1,000
Q3 2020 Oct 26, 2020	BUY	$4.32 - $11.7 $1,291 - $3,498	299 New	299 $1,000
Q2 2020 Jul 06, 2020	SELL	$2.94 - $9.1 $414 - $1,283	-141 Closed	0 $0
Q1 2020 Apr 13, 2020	BUY	$2.27 - $6.2 $320 - $874	141 New	141 $0

257

132M

371K

99.2K

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.44B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

Stay updated on Ellevest, Inc. with notifications on news.